Kalemapex tablets are an important oral medication used primarily to prevent kidney stones from forming and recurring in individuals prone to this painful and irritating condition. These tablets contain the active ingredient potassium citrate at a precise and specific concentration of 15 milliequivalents (mEq), equivalent to 1620 milligrams (mg) of potassium citrate per tablet. This specially formulated concentration modifies the chemical properties of urine in a way that effectively reduces the risk of precipitation of salts and minerals that make up kidney stones, thus contributing to the long-term prevention of their formation or recurrence. Kalemapex tablets are an integral part of the comprehensive therapeutic strategies doctors use to manage chronic kidney stones and improve the quality of life of patients suffering from this recurring health problem.
The active ingredient in Kalemapex tablets
Kalemapex tablets contain the following main active ingredient, which is responsible for its potential preventive and therapeutic effect on kidney stones:
Potassium Citrate: Each Kalemapex tablet contains 15 milliequivalents (mEq), equivalent to 1620 milligrams (mg) of pure potassium citrate. Potassium citrate acts as an alkaline salt that helps increase urine pH (make it less acidic). This increased alkalinity of urine reduces the ability of certain chemicals, such as uric acid and cystine, to crystallize and form stones. In addition, citrate ions bind to calcium in urine, reducing the amount of free calcium available to bind to oxalate and phosphate, the main components of other common types of kidney stones, such as calcium oxalate and calcium phosphate stones. Through these multiple mechanisms, potassium citrate helps prevent the formation of various types of kidney stones and reduces the likelihood of their recurrence. It may also help dissolve some small stones or prevent their growth.
Available Strengths
Kalemapex tablets are primarily available in this specific strength of potassium citrate, 15 mEq (1620 mg) per tablet. This strength is considered a standard and effective dose for many patients seeking to prevent recurrent kidney stone formation. Pack sizes containing these tablets may vary depending on the manufacturer, geographic region, and local market. It is always important to check the package and leaflet for accurate information about pack size and the number of tablets contained.
The daily dose and frequency of taking Kalemapex tablets are determined by the treating physician individually for each patient. This determination is based on a comprehensive assessment of factors such as the type of kidney stone the patient suffers from (if known), current urine pH, medical history, kidney function, and any other medications the patient may be taking. It is essential to strictly adhere to the physician's instructions regarding the dosage and timing of taking the medication to achieve the best therapeutic and preventive results.